By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Invitrogen Corporation 

5791 Van Allen Way
P.O. Box 6482
Carlsbad  California  92008  U.S.A.
Phone: 760-603-7200 Fax: 760-602-6500


Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions as well as pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery, including functional genomics, proteomics, bioinformatics and cell biology - placing Invitrogen's products in nearly every major laboratory in the world.

Founded in 1987, Invitrogen is celebrating 20 years of accelerating scientific discovery. The company is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.3 billion in 2007. Invitrogen has eight manufacturing locations in North America, Europe and Asia, operations in more than 20 countries, and distributor relationships in 70 countries worldwide.

Corporate Management:

  • Gregory T. Lucier - Chairman and CEO
  • David F. Hoffmeister - Senior Vice President, Chief Financial Officer
  • Claude D. Benchimol, Ph.D.- Senior Vice President, Advanced Systems R & D
  • John A. Cottingham - Senior Vice President, General Counsel and Corporate Secretary
  • Peter Leddy, Ph. D.- Senior Vice President, Human Resources
  • Paul Grossman, Ph.D. - Senior Vice President, Strategy and Corporate Development
  • Nicolas M. Barthelemy - Senior Vice President, Cell Culture Systems
  • Kip Miller - Senior Vice President, BioDiscovery
  • Amanda Clardy - Vice President, Investor Relations
  • Kelli Richard - Vice President, Finance & Chief Accounting Officer
  • Bernd Brust - Senior Vice President, Global Sales and Marketing

    Business Units:
    Functional Genomics, Drug Discovery Solutions, Detection Technologies, BioProduction, Cell Culture, Biological Defense Systems

    Key Statistics

    Ownership: Public

    Web Site: Invitrogen Corporation
    Employees: Over 4,300 worldwide
    Symbol: IVGN

  • Industry

    Company News
    Celsis In Vitro Technologies (CEL.L) Seeks Injunction Against Invitrogen Corporation (IVGN) for LiverPool(TM) Patent Infringement 7/1/2010 6:22:15 AM
    Invitrogen Corporation (IVGN) Launches Biomarker Tool for Pre-Clinical Research into Kidney Function 7/30/2009 9:06:36 AM
    Invitrogen Corporation (IVGN) Launches Life Science Industry's First Complete Resource for Cellular Technologies and Education 7/7/2009 9:12:09 AM
    Invitrogen Corporation (IVGN) Launches New Microarray System to Simplify Immunogenetic Testing 6/29/2009 9:51:09 AM
    Invitrogen Corporation (IVGN) Scientists Compile Comprehensive Guidebooks for Stem Cell Research 5/21/2009 9:27:35 AM
    Invitrogen Corporation (IVGN) Launches Enriched Online Retail Experience for Its Award-Winning Website 5/20/2009 10:13:42 AM
    Invitrogen Corporation (IVGN) Develops New Technology to Promote Safer Stem Cell Therapies 5/4/2009 8:59:41 AM
    Invitrogen Corporation (IVGN) Launches Next-Generation Cell Culture Solution for Immunology Research 4/13/2009 9:41:32 AM
    Invitrogen Corporation (IVGN) Introduces Innovation that Speeds Regulatory Filings and Time to Market for Biotherapeutics Manufacturers 4/1/2009 10:25:19 AM
    Invitrogen Corporation (IVGN) Launches Benchtop Device That Simplifies Primary and Stem Cell Research 3/24/2009 9:32:47 AM